lovastatin has been researched along with Atheroma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, C; Jing, Y; Li, P; Li, QZ; Liu, Z; Lu, JX; Niu, HF; Ou, WS; Song, P; Xu, J; Yin, YL; Zhu, ML | 1 |
| Jia, H; Jiang, C; Li, Z; Liu, J; Qi, Z; Tang, Y; Zhang, W | 1 |
| Bai, N; Cheng, JC; Francis, GA; Hiraiwa, K; Miyata, R; Sin, DD; Van Eeden, SF; Vincent, R | 1 |
3 other study(ies) available for lovastatin and Atheroma
| Article | Year |
|---|---|
Citronellal prevents endothelial dysfunction and atherosclerosis in rats.
Topics: Acetylcholine; Acyclic Monoterpenes; Aldehydes; Animals; Anticholesteremic Agents; Aromatherapy; Atherosclerosis; Balloon Occlusion; Carotid Arteries; Cell Movement; Cholecalciferol; Diet, High-Fat; Endothelial Cells; Gene Expression; Humans; Lovastatin; Male; Oxidative Stress; Plaque, Atherosclerotic; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchanger 1; Vasodilation | 2019 |
Rational Design of Lovastatin-Loaded Spherical Reconstituted High Density Lipoprotein for Efficient and Safe Anti-Atherosclerotic Therapy.
Topics: Animals; Atherosclerosis; Cell Survival; Drug Carriers; Drug Compounding; Drug Synergism; Erythrocytes; Hemolysis; Lipoproteins, HDL; Lovastatin; Matrix Metalloproteinases; Mice; Mice, Knockout, ApoE; Nanospheres; Optical Imaging; Plaque, Atherosclerotic; Rabbits; RAW 264.7 Cells; Treatment Outcome | 2019 |
Statins attenuate the development of atherosclerosis and endothelial dysfunction induced by exposure to urban particulate matter (PM10).
Topics: Animals; Atherosclerosis; Blood Vessels; Cholesterol, Dietary; Cyclooxygenase 2; Cytokines; Endothelin-1; Endothelins; Endothelium, Vascular; Environmental Exposure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Lipids; Lovastatin; Male; Nitric Oxide Synthase Type II; Particulate Matter; Plaque, Atherosclerotic; Rabbits; Reactive Oxygen Species; Urban Health; Vascular Diseases | 2013 |